Skip to content

Rethinking stability study management in pharma

Beccy Bell, operations director at testing and regulatory specialist Broughton, examines how stability study management shifts as data moves beyond contained documentation and begins to inform decisions for products already on the market.

Rethinking stability study management in pharma
Published: | 3 min read

Beccy Bell, operations director at Broughton, examines how stability study management shifts as data moves beyond contained documentation and begins to inform decisions for products already on the market.

Broughton

Sign up to our newsletter

The week's biggest stories from this industry, direct to your inbox.

Personal information